Biolinq

Biolinq raises $100M for intradermal glucose sensor for type 2 diabetes

By Jessica Hagen | 12:26 pm | April 22, 2025

The company's patch uses intradermal electrochemical sensors to monitor glucose levels and provide metabolic insights to individuals with type 2 diabetes not on insulin.